InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-09-04 00:00:00 ET · period of report 2024-08-30 · accession 0001477449-24-000185 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-09-04 2024-08-30 TDOC Raman-Tangella Vidya Chief MEDICAL Off M - OptEx — +3,117 32.9K +10% —
D 2024-09-04 2024-09-03 TDOC Raman-Tangella Vidya Chief MEDICAL Off S - Sale+OE $7.16 -1,114 34.1K -3% -$7,976
DM 2024-09-04 2024-08-30 TDOC Raman-Tangella Vidya Chief MEDICAL Off M - OptEx $0.00 -3,117 14.0K -18% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-30 M A 2,325 — 35,247 D — — (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2024-08-30 M A 792 — 32,922 D — — (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Common Common Stock 2024-09-03 S D 1,114 $7.16 34,133 D — — (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
4 Derivative Performance Stock Units 2024-08-30 M D 792 $0.00 4,756 D — · — to — 792 Common Stock (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
5 Derivative Restricted Stock Units 2024-08-30 M D 2,325 $0.00 13,952 D — · — to — 2,325 Common Stock (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.